Trinity Biotech (TRIB)
(Delayed Data from NSDQ)
$2.00 USD
-0.23 (-10.32%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.99 -0.01 (-0.50%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Price, Consensus and EPS Surprise
TRIB 2.00 -0.23(-10.32%)
Will TRIB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TRIB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TRIB
Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout
TRIB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TRIB
Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director
Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript
Trinity Biotech reports Q2 results
TRIB Stock Earnings: Trinity Biotech Reported Results for Q2 2024
Trinity Biotech Announces Q2 2024 Financial Results